Milestone Scientific Inc (MLSS) ニュース

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024

Secured Medicare price assignment for the CompuFlo® Epidural System in multiple U.S. states Gross margin for...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call

ROSELAND, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer...

Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida

ROSELAND, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer...

Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe

ROSELAND, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer...

Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware

ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer...

Form 8-K - Current report

Milestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering Florida

ROSELAND, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer...

Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil

Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back...

Form DEF 14A - Other definitive proxy statements